Huw Jones
Amministratore Delegato presso THERACRYF PLC
Patrimonio netto: 587 $ in data 30/04/2024
Posizioni attive di Huw Jones
Società | Posizione | Inizio | Fine |
---|---|---|---|
THERACRYF PLC | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | 01/10/2020 | - | |
Chronos Therapeutics Ltd.
Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Presidente | - | - |
Direttore/Membro del Consiglio | - | - | |
Amministratore Delegato | - | - | |
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | 12/02/2020 | - |
Storia della carriera di Huw Jones
Precedenti posizioni note di Huw Jones
Società | Posizione | Inizio | Fine |
---|---|---|---|
Sinclair Pharma UK Ltd.
Sinclair Pharma UK Ltd. Miscellaneous Commercial ServicesCommercial Services Sinclair Pharma UK Ltd. provides pharmaceutical services. The company work closely with dispensing doctors to provide products and services that support rural dispensing and help to generate an income for practices. The company was founded in 1984 and is located in Surrey, the United Kingdom. | Presidente | 01/01/2002 | 01/01/2006 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Presidente | 01/01/2004 | - |
Ardana Plc
Ardana Plc Pharmaceuticals: MajorHealth Technology Ardana Plc developed pharmaceuticals products. It offered Invicorp, an intracavernosal injectable combination of phentolamine mesilate and vasoactive intestinal polypeptide for the treatment of male erectile dysfunction. The company was founded in 2000 and was headquartered in Bristol, the United Kingdom. | Direttore/Membro del Consiglio | 01/01/2006 | 08/02/2010 |
Amministratore Delegato | 08/02/2010 | - |
Formazione di Huw Jones
University of Birmingham | Doctorate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 7 |
Stati Uniti | 2 |
Posizioni
Director/Board Member | 4 |
Chief Executive Officer | 3 |
Chairman | 2 |
Settori
Health Technology | 5 |
Commercial Services | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
THERACRYF PLC | Health Services |
Aziende private | 5 |
---|---|
Sinclair Pharma UK Ltd.
Sinclair Pharma UK Ltd. Miscellaneous Commercial ServicesCommercial Services Sinclair Pharma UK Ltd. provides pharmaceutical services. The company work closely with dispensing doctors to provide products and services that support rural dispensing and help to generate an income for practices. The company was founded in 1984 and is located in Surrey, the United Kingdom. | Commercial Services |
Ardana Plc
Ardana Plc Pharmaceuticals: MajorHealth Technology Ardana Plc developed pharmaceuticals products. It offered Invicorp, an intracavernosal injectable combination of phentolamine mesilate and vasoactive intestinal polypeptide for the treatment of male erectile dysfunction. The company was founded in 2000 and was headquartered in Bristol, the United Kingdom. | Health Technology |
Chronos Therapeutics Ltd.
Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
- Borsa valori
- Insiders
- Huw Jones
- Esperienza